Search results
Results From The WOW.Com Content Network
Mounjaro is an FDA-approved medicine used to improve blood sugar (glucose) levels in adults with type 2 diabetes mellitus when used together with diet and exercise. Mounjaro’s active ingredient, tirzepatide, was used in the Phase 3 SURMOUNT-1 72-week weight loss clinical trials.
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes.
Mounjaro is a single peptide designed from the structure of native GIP and modified to bind to the GIP and GLP-1 receptors. While the activity of Mounjaro on the GLP-1 receptor is lower than the activity of the native GLP-1 hormone, the activity of Mounjaro on the GIP receptor is similar to that of the native GIP hormone.
Mounjaro is used to help lower blood sugar levels in people with type 2 diabetes. Mounjaro may also be used for other conditions as determined by your healthcare provider. How does Mounjaro...
Mounjaro is the first and only approved treatment in a different class of medication for type 2 diabetes. * It works differently than other type 2 diabetes medications by directly activating GIP and GLP-1 pathways to help regulate blood sugar.
Learn about uses, side effects, and more for Mounjaro (tirzepatide). It’s a prescription injection that helps manage blood sugar in adults with type 2 diabetes.
Tirzepatide - Wikipedia. Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes [10][13][14][15] and for weight loss. [11][16] Tirzepatide is administered via subcutaneous injections (under the skin). [10][13] It is sold under the brand names Mounjaro for diabetes treatment, [10] and Zepbound for weight loss. [11]